Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center

CONCLUSIONS: The combined regimen of venetoclax and azacitidine may be beneficial for patients with R/R B-ALL.PMID:38666535 | DOI:10.1080/16078454.2024.2344998

Source: Hematology - April 26, 2024 Category: Hematology Authors: Ziyi Hao Yingying Fei Juan Chen Sailan Huang Li Wang Youhuan Yu Meiru Bian Yejun Si Xingxia Zhang Xiaotian Yang Bing Zhang Yan Wan Yanming Zhang Guoqiang Lin Source Type: research